Liana K. Billings
Expertise in
28
conditions

Dr. Liana K. Billings

Endocrinology | Medical Genetics
9977 Woods Dr., Suite 300, 
Skokie, IL 
Accepting New Patients
Offers Telehealth
Referral required
Before you request
Expertise in
28
conditions
9977 Woods Dr., Suite 300, 
Skokie, IL 

Overview

Liana Billings, MD, an endocrinologist and clinical researcher at Endeavor Health, specializes in diabetes care and cardiometabolic disease. She serves as Vice Chair of Research for the Department of Medicine and directs the Clinical and Genetics Research Program in Diabetes and Cardiometabolic Disease. Dr. Billings focuses on precision medicine to better understand how genetics influence diagnosis, treatment and outcomes. Through her Precision Medicine in Diabetes Consultation Clinic, she partners with patients to personalize therapies and improve quality of life, including for those with rare forms of diabetes.

Dr. Billings is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Maturity Onset Diabetes of the Young, and Low Blood Sugar.

Dr. Billings is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 60 peer reviewed articles and participating in 6 clinical trials. Dr. Billings is currently accepting new patients.

Specialties

Endocrinology
Medical Genetics

Licenses

Internal Medicine in MA

Board Certifications

American Board Of Internal Medicine

Fellowships

McGaw Medical Center of Northwestern University, Endocrinology, 2008
Massachusetts General Hospital, Endocrinology, 2011

Hospital Affiliations

Swedish Hospital
Northshore University Healthsystem - Evanston Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 19 Less Insurance Carriers -

Locations

Endeavor Health Medical Group
9977 Woods Dr., Suite 300, Skokie, IL 60077

Additional Areas of Focus

Dr. Billings has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Enrollment Status: Completed
Publish Date: May 13, 2026
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
Enrollment Status: Completed
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Phase: Phase 1
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Osteoarthritis Pain
Enrollment Status: Completed
Publish Date: July 17, 2024
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3556050 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Terminated
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drug: LY3556050
Study Phase: Phase 2
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
View 5 Less Clinical Trials

60 Total Publications

Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
Journal: Lancet (London, England)
Published: April 17, 2026
Similar Doctors
Expertise in
23
conditions
Dr. Barbara K. Burton
Medical Genetics | Pediatrics
Expertise in
23
conditions
Dr. Barbara K. Burton
Medical Genetics | Pediatrics
Referral may be required
2300 Childrens Plaza, 
Chicago, IL 
 (11.1 miles away)
773-880-4462
Languages Spoken:
English
See accepted insurances

Barbara Burton is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois. Dr. Burton is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 2 (MPS II, Hunter Syndrome), Phenylketonuria (PKU), Mucopolysaccharidoses (MPS), and Cholesteryl Ester Storage Disease.

Expertise in
46
conditions
Dr. Joel M. Charrow
Medical Genetics | Pediatrics
Expertise in
46
conditions
Dr. Joel M. Charrow
Medical Genetics | Pediatrics
Referral may be required

Lurie Children's Medical Group Inc.

225 E Chicago Ave, 
Chicago, IL 
 (13.4 miles away)
312-227-6415
Languages Spoken:
English
See accepted insurances

Joel Charrow is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois. Dr. Charrow is highly rated in 46 conditions, according to our data. His clinical expertise encompasses Gaucher Disease Type 1, Gaucher Disease, Achondroplasia, Isovaleric Acidemia, and Splenectomy.

Expertise in
172
conditions
Dr. Carlos E. Prada
Medical Genetics | Pediatrics
Expertise in
172
conditions
Dr. Carlos E. Prada
Medical Genetics | Pediatrics
Referral may be required

Lurie Children's Medical Group Inc.

225 E Chicago Ave, 
Chicago, IL 
 (13.4 miles away)
312-227-6415
Languages Spoken:
English
See accepted insurances

Carlos Prada is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Chicago, Illinois. Dr. Prada is highly rated in 172 conditions, according to our data. His clinical expertise encompasses RASopathies, Neurofibromatosis Type 1 (NF1), Neurofibromatosis, and Smith-Kingsmore Syndrome.

Frequently Asked Questions about Dr. Liana K. Billings

How do I make an appointment with Dr. Liana K. Billings?

You can book an appointment with Dr. Liana K. Billings by calling their office at 847-663-8540. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Liana K. Billings a top-rated expert for Type 2 Diabetes (T2D)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Liana K. Billings is classified as an Elite expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Liana K. Billings specialize in?

While Dr. Liana K. Billings is a Endocrinology, they have specific expertise in Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), and Maturity Onset Diabetes of the Young. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.

Does Dr. Liana K. Billings participate in research or clinical trials?

Yes. Dr. Liana K. Billings has published 60 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Dr. Liana K. Billings's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Liana K. Billings accept my insurance?

Dr. Liana K. Billings accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-663-8540 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Billings's expertise for a condition
ConditionClose
View All 24 Advanced Conditions
View All 47 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile